Skip to main content
. 2015 Feb 19;19(1):67. doi: 10.1186/s13054-015-0787-y

Figure 1.

Figure 1

The likelihood of dexmedetomidine (D) to result in lower total intensive care unit costs than pooled standard care sedatives (SC), assessed by bootstrapping. As indicated by the black circle, the likelihood that dexmedetomidine results in lower total intensive care unit costs than the standard sedatives is 91.0%.